Nurse Practitioner, Adult Health · Wynnewood, PA
NPI
1982670527
Since 2006
Specialty
Nurse Practitioner, Adult Health
Code 363LA2200X
Group practices
1
Medicare group memberships
Hospitals
4
Hospital affiliations
100 E Lancaster Ave Ste 560
Wynnewood, PA, 19096
Phone (610) 649-1922
Groups this clinician bills Medicare through
Medicare paid, 2024
$103K
1,576 services
Medicare patients, 2024
432
Average age 73
Drug cost, 2024
$5.0M
8,684 prescriptions
Company payments, 2025
$5,426
From 25 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Donna M Steel was code 99214 (office e&m - established), 482 times for 246 patients. In total Donna M Steel billed 1,576 services in 11 codes, and Medicare paid $103K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2018-01-05.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 482 | 246 | $76.79 | $37K |
| 99215 Office E&M - Established | Office | 394 | 197 | $112.95 | $45K |
| 82962 Clinical Chemistry | Office | 195 | 138 | $3.15 | $614 |
| 99443 Telephone Services | Office | 155 | 108 | $69.47 | $11K |
| 99205 Office E&M - New | Office | 30 | 30 | $137.37 | $4,121 |
| 95251 Test - Miscellaneous | Office | 11 | 11 | $21.53 | $237 |
By year: 2022 $108K for 2,179 services; 2023 $103K for 1,689 services; 2024 $103K for 1,576 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 82962 Clinical Chemistry | 195 | 138 | $3.15 | $614 |
Medicare prescription drug claims, 2024
In 2024, the drug Donna M Steel prescribed most often to Medicare patients was Jardiance (Empagliflozin), with 859 prescriptions and refills. In total Donna M Steel wrote 8,684 Medicare prescriptions that cost $5.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Jardiance Empagliflozin | 859 | 1,805 | 229 | $1.0M |
| Ozempic Semaglutide | 748 | 1,239 | 150 | $1.2M |
| Mounjaro Tirzepatide | 652 | 788 | 99 | $810K |
| Metformin Hcl Er Metformin Hcl | 503 | 1,295 | 131 | $11K |
| Metformin Hcl Generic | 485 | 1,325 | 148 | $6,650 |
| Atorvastatin Calcium Generic | 336 | 928 | 104 | $4,822 |
| Nano 2nd Gen Pen Needle Pen Needle, Diabetic | 290 | 715 | 123 | $32K |
| Glimepiride Generic | 220 | 628 | 70 | $2,945 |
| Farxiga Dapagliflozin Propanediol | 218 | 373 | 51 | $202K |
| Lantus Solostar Insulin Glargine,hum.Rec.Anlog | 214 | 535 | 84 | $25K |
| Rosuvastatin Calcium Generic | 210 | 574 | 65 | $4,775 |
| Novolog Flexpen Insulin Aspart | 206 | 416 | 74 | $53K |
| Levothyroxine Sodium Generic | 205 | 577 | 61 | $3,171 |
| Tresiba Flextouch U-200 Insulin Degludec | 180 | 403 | 45 | $152K |
| Repaglinide Generic | 179 | 404 | 49 | $5,801 |
Brand drugs: 4,871 claims; generic drugs: 3,223 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Donna M Steel $5,426 ($5,426 in general payments such as food, travel and fees) from 25 companies. The largest payer was Novo Nordisk Inc with $689.
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc NVO | 35 | $689 |
| Abbott Laboratories ABT | 34 | $678 |
| Amgen Inc. AMGN | 23 | $669 |
| Lilly USA, LLC LLY | 26 | $643 |
| Tandem Diabetes Care, Inc. TNDM | 13 | $467 |
| Medtronic, Inc. MDT | 8 | $345 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 11 | $258 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 15 | $242 |
| Sanofi-Aventis U.S. LLC SNY | 9 | $188 |
| Averitas Pharma Inc. | 8 | $173 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.